Annual report
5162.TEDINET S100OBHC
Period2021-04-01 → 2022-03-31
Filed2022-06-21
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥6.5bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥7.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.7bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.5bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥291m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | −¥93m | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥313m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥18m | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥347m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥509m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥590m | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥305m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥155m | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥238m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥114m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥127m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥352m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥459m | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥238m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥114m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥9.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥10.3bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥10.4bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥10.4bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥10.5bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.0bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥5.9bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.4bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.5bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥4.5bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥4.3bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥956m | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥848m | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥834m | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.2bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥436m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥719m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥872m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥541m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥214m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥55m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥644m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥748m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥801m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥762m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥50m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥208m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥107m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥448m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥52.56 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.06 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.91 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥77.97 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.98 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,030.86 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥976.73 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥979.9 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥987.28 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥958.48 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 48.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.8% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.9% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.8% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.2% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.2% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.6% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 508 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 514 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 528 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 561 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 488 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥6.4bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥6.1bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥6.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.0bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥216m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | −¥54m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥241m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥83m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥300m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥400m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥445m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥231m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥220m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥175m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥175m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥79m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥271m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥354m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥8.9bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥9.7bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥9.7bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.8bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.9bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥4.9bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.8bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥4.1bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.0bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.9bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥4.0bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.8bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.6bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥38.64 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.51 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.51 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.87 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.68 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥20 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥892.96 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥876.01 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥860.74 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥874.45 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥853.08 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 45.3% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.8% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.3% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.0% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.4% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.4% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.0% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.6% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 4,618,520 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,618,520 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,618,520 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,618,520 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,618,520 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 315 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 313 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 318 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 306 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 281 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| Industrial Rubber Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥120m |
| Industrial Rubber Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥339m |
| Industrial Rubber Businessreportable segment | employees | at 2022-03-31 | 386 pure |
| Industrial Rubber Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥5.8bn |
| Industrial Rubber Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥5.8bn |
| Industrial Rubber Businessreportable segment | segment assets | at 2022-03-31 | ¥5.4bn |
| Industrial Rubber Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥530m |
| Rubber Business For Medical Care Hygienereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥41m |
| Rubber Business For Medical Care Hygienereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥102m |
| Rubber Business For Medical Care Hygienereportable segment | employees | at 2022-03-31 | 78 pure |
| Rubber Business For Medical Care Hygienereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Rubber Business For Medical Care Hygienereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Rubber Business For Medical Care Hygienereportable segment | segment assets | at 2022-03-31 | ¥1.4bn |
| Rubber Business For Medical Care Hygienereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥99m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥161m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥441m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥6.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥629m |
| Industrial Rubber Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥168m |
| Industrial Rubber Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥380m |
| Industrial Rubber Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥5.3bn |
| Industrial Rubber Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥5.3bn |
| Industrial Rubber Businessreportable segment | segment assets | at 2021-03-31 | ¥5.4bn |
| Industrial Rubber Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥121m |
| Rubber Business For Medical Care Hygienereportable segment | capex | 2020-04-01 → 2021-03-31 | ¥77m |
| Rubber Business For Medical Care Hygienereportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥113m |
| Rubber Business For Medical Care Hygienereportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Rubber Business For Medical Care Hygienereportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Rubber Business For Medical Care Hygienereportable segment | segment assets | at 2021-03-31 | ¥1.4bn |
| Rubber Business For Medical Care Hygienereportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥113m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥245m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥492m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥6.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥234m |
| Industrial Rubber Businessreportable segment | employees | at 2022-03-31 | 207 pure |
| Rubber Business For Medical Care Hygienereportable segment | employees | at 2022-03-31 | 77 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,437
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from sales of property plant and equipment inv cf | Prior1YearDuration | 75000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYearDuration | 883000 | JPY |
| Purchase of intangible assets inv cf | Prior1YearDuration | － | JPY |
| Purchase of intangible assets inv cf | CurrentYearDuration | -1870000 | JPY |
| Purchase of investment securities inv cf | Prior1YearDuration | -1237000 | JPY |
| Purchase of investment securities inv cf | CurrentYearDuration | -1263000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YearDuration | 225641000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYearDuration | － | JPY |
| Proceeds from redemption of investment securities inv cf | Prior1YearDuration | 89507000 | JPY |
| Proceeds from redemption of investment securities inv cf | CurrentYearDuration | － | JPY |
| Other net inv cf | Prior1YearDuration | 47093000 | JPY |
| Other net inv cf | CurrentYearDuration | -5683000 | JPY |
| Net cash provided by used in investment activities | Prior1YearDuration | -54982000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration | -214256000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YearDuration | -8066000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYearDuration | － | JPY |
| Proceeds from long term loans payable fin cf | Prior1YearDuration | 1300000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYearDuration | 500000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YearDuration | -1225874000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration | -1164565000 | JPY |
| Purchase of treasury stock fin cf | Prior1YearDuration | -16388000 | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration | － | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -91072000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -90667000 | JPY |
| Other net fin cf | Prior1YearDuration | -8151000 | JPY |
| Other net fin cf | CurrentYearDuration | -6571000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -49553000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | -761803000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | -5680000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration | 39605000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 609075000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | -500498000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 847698000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1456773000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1456773000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 956275000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 5 | |
| Accumulated depreciation ppe by group | Prior1YearInstant | -7082725000 | JPY |
| Accumulated depreciation ppe by group | CurrentYearInstant | -7513451000 | JPY |
| Directors compensations sga | Prior1YearDuration | 136443000 | JPY |
| Directors compensations sga | CurrentYearDuration | 130800000 | JPY |
| Salaries and allowances sga | Prior1YearDuration | 410608000 | JPY |
| Salaries and allowances sga | CurrentYearDuration | 415953000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 35087000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 35434000 | JPY |
| Provision for share based remuneration for directors and other officers sga | Prior1YearDuration | 5668000 | JPY |
| Provision for share based remuneration for directors and other officers sga | CurrentYearDuration | 5728000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 191218000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 209140000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 191218000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |